Prr seem to have been developing nicely and although a biased...

Prr seem to have been developing nicely and although a biased opinion managemnet claims that the value of their intellectual property far exceeds the current share price.
Their portfolio of research projects focus on the following areas:
-technology that has the potential to both prevent and treat Malaria
-development of tumour antigens to target cancer cells of the breast, lungs, colon, ovaries and prostate
-development of new drugs for rheumatoid athritis
-producing an immune response in large animals leading to a vaccination against foot and mouth disease.
Several licences and royalties in the pipeline with significant announcements due in July. Worth a punt at current levels, who knows how this one may run if any one of their technologies is a hit.